These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8758211)
1. Cadherin expression in melanocytic naevi and malignant melanomas. Cowley GP; Smith ME J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211 [TBL] [Abstract][Full Text] [Related]
2. E-cadherin/catenin complex in benign and malignant melanocytic lesions. Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482 [TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays. Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225 [TBL] [Abstract][Full Text] [Related]
4. Micro-anatomy related antigen expression in melanocytic lesions. Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983 [TBL] [Abstract][Full Text] [Related]
5. Expression of neurotrophins and their receptors in pigment cell lesions of the skin. Innominato PF; Libbrecht L; van den Oord JJ J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147 [TBL] [Abstract][Full Text] [Related]
6. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105 [TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148 [TBL] [Abstract][Full Text] [Related]
8. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Petersson S; Shubbar E; Enerbäck L; Enerbäck C Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263 [TBL] [Abstract][Full Text] [Related]
9. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837 [TBL] [Abstract][Full Text] [Related]
10. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Fröhlich E; Mack AF; Garbe C; Klessen C Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652 [TBL] [Abstract][Full Text] [Related]
11. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas. Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155 [TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis? De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173 [TBL] [Abstract][Full Text] [Related]
17. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Kuphal S; Bosserhoff AK Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038 [TBL] [Abstract][Full Text] [Related]
18. S100A6 protein expression is different in Spitz nevi and melanomas. Ribé A; McNutt NS Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of growth hormone receptor immunoreactivity in human melanoma. Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]